Proprotein Convertase Subtilisin-Kexin Type 9 inhibitors and stroke prevention: A meta-analysis

Dimitrios Sagris; George Ntaios; Georgios Georgiopoulos; Konstantinos Pateras; Haralampos Milionis

doi:10.1016/j.ejim.2020.11.021

Proprotein Convertase Subtilisin-Kexin Type 9 inhibitors and stroke prevention: A meta-analysis

Dimitrios Sagris^*
, George Ntaios
, Georgios Georgiopoulos
, Konstantinos Pateras
, Haralampos Milionis

^*Corresponding author for this work

Circulatory Health

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

2 Downloads (Pure)

Original language	English
Pages (from-to)	130-132
Number of pages	3
Journal	European journal of internal medicine
Volume	85
Issue number	3
DOIs	https://doi.org/10.1016/j.ejim.2020.11.021
Publication status	Published - Mar 2021

Keywords

Alirocumab
Evolocumab
Lipid-lowering
PCSK9 inhibitor
Statin
Stroke

Access to Document

10.1016/j.ejim.2020.11.021

1-s2.0-S0953620520304313-mainFinal published version, 709 KBLicence: Taverne

Cite this

@article{c64c9c3c9ee94a6793d5ea83aee3605c,

title = "Proprotein Convertase Subtilisin-Kexin Type 9 inhibitors and stroke prevention: A meta-analysis",

keywords = "Alirocumab, Evolocumab, Lipid-lowering, PCSK9 inhibitor, Statin, Stroke",

author = "Dimitrios Sagris and George Ntaios and Georgios Georgiopoulos and Konstantinos Pateras and Haralampos Milionis",

year = "2021",

month = mar,

doi = "10.1016/j.ejim.2020.11.021",

language = "English",

volume = "85",

pages = "130--132",

journal = "European journal of internal medicine",

issn = "0953-6205",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Proprotein Convertase Subtilisin-Kexin Type 9 inhibitors and stroke prevention

T2 - A meta-analysis

AU - Sagris, Dimitrios

AU - Ntaios, George

AU - Georgiopoulos, Georgios

AU - Pateras, Konstantinos

AU - Milionis, Haralampos

PY - 2021/3

Y1 - 2021/3

KW - Alirocumab

KW - Evolocumab

KW - Lipid-lowering

KW - PCSK9 inhibitor

KW - Statin

KW - Stroke

UR - https://www.scopus.com/pages/publications/85099717070

U2 - 10.1016/j.ejim.2020.11.021

DO - 10.1016/j.ejim.2020.11.021

M3 - Comment/Letter to the editor

C2 - 33419661

SN - 0953-6205

VL - 85

SP - 130

EP - 132

JO - European journal of internal medicine

JF - European journal of internal medicine

IS - 3

ER -

Proprotein Convertase Subtilisin-Kexin Type 9 inhibitors and stroke prevention: A meta-analysis

Keywords

Access to Document

Other files and links

Cite this